ViaWealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$610K Sell
2,494
-8
-0.3% -$1.86K 0.34% 87
2025
Q4
$518K Sell
2,502
-397
-14% -$78.5K 0.29% 95
2025
Q3
$538K Buy
2,899
+17
+0.6% +$2.91K 0.29% 95
2025
Q2
$440K Sell
2,882
-1,662
-37% -$255K 0.26% 110
2025
Q1
$754K Buy
+4,544
New +$711K 0.47% 66
2024
Q1
Sell
-1,316
Closed -$206K 157
2023
Q4
$206K Buy
1,316
+4
+0.3% +$613 0.14% 148
2023
Q3
$204K Sell
1,312
-1,570
-54% -$259K 0.15% 152
2023
Q2
$477K Buy
2,882
+10
+0.3% +$1.61K 0.36% 96
2023
Q1
$445K Buy
2,872
+123
+4% +$19.9K 0.35% 101
2022
Q4
$483K Buy
+2,749
New +$475K 0.4% 91

Other funds holding JNJ

ViaWealth's JNJ Position: Q1 2026 in Review

ViaWealth reduced its Johnson & Johnson (JNJ) stake by 0.32% in Q1 2026, selling an estimated $1.86K and leaving 2,494 shares worth $610K. The position accounts for 0.34% of the portfolio, ranked #87.

ViaWealth first reported a position in JNJ in Q4 2022 and has held it in 10 quarters since. The position peaked at $754K in Q1 2025. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • ViaWealth held 2,494 shares of Johnson & Johnson worth $610K as of Q1 2026.
  • ViaWealth sold 8 Johnson & Johnson shares in Q1 2026, an estimated $1.86K.
  • Johnson & Johnson made up 0.34% of ViaWealth's portfolio in Q1 2026, its #87 holding.
  • ViaWealth first reported a position in Johnson & Johnson in Q4 2022 and has held it in 10 quarters since.
  • ViaWealth's Johnson & Johnson position peaked at $754K in Q1 2025.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on ViaWealth's 13F filing for Q1 2026, filed 11 May 2026.